BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Despite the challenges of the past few years\, 2021 saw a cont
 inued return to normal deal-making activity in the life sciences sector a
 s pharma and biotech companies quickly adapted and readjusted their busin
 ess goals leading to a reinvigorated marketplace ripe with new opportunit
 ies but also with new challenges and risks. Now is the ideal time for lif
 e sciences companies to capitalize on the innovation and investment oppor
 tunities in the industry and build a comprehensive business development s
 trategy for 2022.\n\nWith so much at stake\, it is essential for life sci
 ence organizations to effectively assess the risks associated with a deal
 \, explore innovative models and deal structures for working with strateg
 ic partners\, collaborate with cross-functional partners to realize busin
 ess synergies and develop processes for the efficient and optimal negotia
 tion and closing of a transaction.\n\nWith this in mind\, the 3rd Fierce 
 BD&amp\;L Summit returns LIVE in 2022 bringing together key deal-makers a
 nd serving as an open forum for cross-functional business development\, d
 ue diligence\, finance\, and legal teams to share valuable insights and a
 ctionable strategies on successfully sourcing and evaluating new opportun
 ities\, conducting due diligence\, and structuring licensing agreements a
 nd M&amp\;A deals. This year’s conference features expanded networking op
 portunities along with two days of panels\, case studies\, and practical 
 sessions across three critical topic areas – Business Development\, Due D
 iligence\, and Legal/IP.\n
DTEND:20220316T170000
DTSTAMP:20260307T160215Z
DTSTART:20220315T080000
LOCATION:Hyatt Centric Fisherman's Wharf San Francisco\, 555 North Point S
 treet\, San Francisco\, California\, 94133\,
SEQUENCE:0
SUMMARY:Despite the challenges of the past few years\, 2021 saw a continue
 d return to normal deal-making activity in the life sciences sector as ph
 arma and...
UID:acc22fca-1b62-42b0-a414-523a84c652ef
END:VEVENT
END:VCALENDAR
